# News

-

April 14th, 2026· 4.7 min·

###### [PolarisQB Demonstrates Advances in Drug Safety Prediction with Quantum-Inspired AI, Enabling Earlier Elimination of Toxic Compounds from Discovery Pipeline](https://polarisqb.com/polaris-news/polarisqb-demonstrates-advances-in-drug-safety-prediction-with-quantum-inspired-ai-enabling-earlier-elimination-of-toxic-compounds-from-discovery-pipeline/)

PolarisQB advances drug safety prediction with quantum-inspired AI, enabling early removal

-

April 14th, 2026· 0.7 min·

###### [Polaris Quantum Biotech has been selected as a 2026 winner of the Cleveland Clinic Quantum Innovation Catalyzer Program](https://polarisqb.com/polaris-news/polaris-quantum-biotech-has-been-selected-as-a-2026-winner-of-the-cleveland-clinic-quantum-innovation-catalyzer-program/)

DURHAM, NC - Polaris Quantum Biotech has been selected as a

-

November 22nd, 2025· 2.9 min·

###### [PolarisQB Published A Manuscript Demonstrating The Superiority Of Quantum Computing Over AI In Drug Design](https://polarisqb.com/polaris-news/polarisqb-published-a-manuscript-demonstrating-the-superiority-of-quantum-computing-over-ai-in-drug-design/)

DURHAM, NC - Polaris Quantum Biotech (PolarisQB), a leader in

-

October 2nd, 2025· 1.8 min·

###### [PolarisQB Receives DARPA EEI Award to Advance Quantum Computing for Drug Design](https://polarisqb.com/polaris-news/polarisqb-receives-darpa-eei-award-to-advance-quantum-computing-for-drug-design/)

DURHAM, NC - The Defense Advanced Research Projects Agency (DARPA)

-

August 12th, 2025· 2.7 min·

###### [Polaris Quantum Biotech Unveils QuADD: Next-Generation Quantum-AI Drug Discovery Platform – Beta Testers Wanted](https://polarisqb.com/polaris-news/polarisqb-unveils-quadd-nextgen-quantum-ai-drug-discovery-platform/)

DURHAM, NC - Polaris Quantum Biotech (PolarisQB), a leader in

-

February 28th, 2025· 1.3 min·

###### [An Investigation of Allostery in Epidermal Growth Factor Receptor Using Sextant with Dynamics Simulations to Expand an Apo Site](https://polarisqb.com/polaris-news/an-investigation-of-allostery-in-epidermal-growth-factor-receptor-using-sextant-with-dynamics-simulations-to-expand-an-apo-site/)

Introduction Computational drug design typically requires a well-defined protein-ligand complex.

-

January 12th, 2025· 0.8 min·

###### [Quantum-Aided Drug Design for Inhibiting Protein-Protein Interactions for Emerging Threats](https://polarisqb.com/polaris-news/quantum-aided-drug-design-for-inhibiting-protein-protein-interactions-for-emerging-threats/)

Introduction The DARPA IMPAQT ARC Opportunity solicited ideas to

-

November 24th, 2024· 1.2 min·

###### [Hybrid Quantum Approach for Sampling Molecular Fragment Libraries to Discover Novel Therapeutics for Ebola](https://polarisqb.com/polaris-news/hybrid-quantum-approach-for-sampling-molecular-fragment-libraries/)

Introduction Fragment-based drug design (FBDD) uses molecular fragments to identify

-

November 10th, 2024· 1.1 min·

###### [Sextant: A New Tool for Designing Custom Molecular Templates for Protein-Protein Interaction Inhibitor Drug Design](https://polarisqb.com/polaris-news/sextant-a-new-tool-for-designing-custom-molecular-templates-for-protein-protein-interaction-inhibitor-drug-design/)

Introduction Inhibiting Protein-Protein Interactions (PPIs) with small molecules is

-

October 18th, 2024· 0.7 min·

###### [Webinar: Using QuaDD to Accelerate Discovery for Versatile Targets](https://polarisqb.com/polaris-news/quadd-webinar-find-your-star-molecule-2/)

On Tuesday, October 1, PolarisQB hosted a webinar titled "Find